http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2253423-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 |
| filingDate | 2004-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25a93fe55297e2c0319ce16e4c20c1d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e304cdbbabf93e44b60eb3b8027458b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eefce7e97c558e90facde81d11d9fa0 |
| publicationDate | 2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2253423-C1 |
| titleOfInvention | Combined method for removing intraocular neoplasm |
| abstract | FIELD: medicine. n SUBSTANCE: method involves carrying out vitrectomy, retinotomy, exposing the intraocular neoplasm, surgically removing the intraocular neoplasm, smoothing retina with perfluororganic compound and substituting the perfluororganic compound with silicon oil. After having removed the perfluororganic compound, 10% ozonized Perfluoran emulsion having ozone concentration of 2-4 mg/l is intravenously introduced. Photosensibilizer agent is introduced into cubital vein of the same arm during 5-10 min. Intravenous laser radiation treatment of blood in 5-15 min after beginning photosensibilizer agent injection with wavelength corresponding to maximum light absorption value characteristic of the photosensibilizer agent within 10-45 min under radiation power required for activating photochemical process. Smoothing retina with perfluororganic compound being completed, separating endoscopic laser coagulation of retinotomy region is carried out with diode laser. 1-3 months later, ozonized Perfluoran emulsion, photosensibilizer agent and intravenous laser radiation treatment are repeatedly applied. n EFFECT: enhanced effectiveness of treatment; reduced risk of tumor cell dissemination. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2447869-C1 |
| priorityDate | 2004-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.